Search by Drug Name or NDC

    NDC 69639-0101-04 AKYNZEO 300; .5 mg/1; mg/1 Details

    AKYNZEO 300; .5 mg/1; mg/1

    AKYNZEO is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Helsinn Therapeutics (U.S.), Inc.. The primary component is NETUPITANT; PALONOSETRON.

    Product Information

    NDC 69639-0101
    Product ID 69639-101_3730c0de-198d-4359-8dbd-aaaf47814560
    Associated GPIs 50309902290120
    GCN Sequence Number 072935
    GCN Sequence Number Description netupitant/palonosetron HCl CAPSULE 300-0.5 MG ORAL
    HIC3 H6J
    HIC3 Description ANTIEMETIC/ANTIVERTIGO AGENTS
    GCN 37239
    HICL Sequence Number 041467
    HICL Sequence Number Description NETUPITANT/PALONOSETRON HCL
    Brand/Generic Brand
    Proprietary Name AKYNZEO
    Proprietary Name Suffix n/a
    Non-Proprietary Name Netupitant and Palonosetron
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 300; .5
    Active Ingredient Units mg/1; mg/1
    Substance Name NETUPITANT; PALONOSETRON
    Labeler Name Helsinn Therapeutics (U.S.), Inc.
    Pharmaceutical Class Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], P-Glycoprotein Inhibitors [MoA], Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC], Substance P/Neurokinin
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA205718
    Listing Certified Through 2024-12-31

    Package

    NDC 69639-0101-04 (69639010104)

    NDC Package Code 69639-101-04
    Billing NDC 69639010104
    Package 2 BLISTER PACK in 1 CARTON (69639-101-04) / 2 CAPSULE in 1 BLISTER PACK
    Marketing Start Date 2014-10-13
    NDC Exclude Flag N
    Pricing Information N/A